Vera Therapeutics Inc (VERA) (Q3 2026) Earnings Call Highlights: TRUTAKNA Launch Off to a ...
Vera Therapeutics Inc (VERA) reported its first partial quarter of TRUTAKNA sales at $10.3 million and roughly 700 patient start forms, while advancing a supplemental BLA for full approval. Related Stocks: VERA ,